Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer

NCT00327743 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Cancer

Interventions

DRUG: larotaxel
DRUG: capecitabine

Sponsor

Sanofi